Senior Director, Discovery Sciences
Job description
About Slate Medicines
Slate Medicines is a clinical-stage biotech company developing next-generation therapeutics for migraine and other headache disorders. Its lead program, SLTE-1009, is a subcutaneous monoclonal antibody targeting both PACAP and VIP, with the potential to be a best-in-class option for migraine prevention; the program entered Phase 1 in 2026, with topline data expected in mid-2027 and a Phase 2 start planned for 2027. Slate is backed by leading healthcare investors including RA Capital Management, Forbion, Foresite Capital, and Frazier Life Sciences, and is on track to become a publicly traded company (Nasdaq: SLTE) through a planned merger with Fulcrum Therapeutics.
- Own in vitro and in vivo target validation strategy from early target hypothesis through development candidate (DC) nomination, including cell-based and animal models that establish target engagement, mechanism of action, and translatability to the clinic
- Lead GPCR and ion channel pharmacology, including PACAP/VIP receptor biology (PAC1, VPAC1, VPAC2), and apply that expertise to new targets as the pipeline grows
- Build and validate disease-relevant in vivo models, such as migraine pharmacology models, that produce decision-grade efficacy and mechanism data for go/no-go calls
- Build a discovery function that isn’t tied to one modality: support biologics today and small molecules, peptides or other modalities as the pipeline expands, and partner with the CSO on choosing the right modality for each new target
- Define discovery-to-development handoff criteria so programs enter nonclinical development with validated targets, characterized mechanism and de-risked biology
- Lead programs from target validation through DC nomination and handoff to nonclinical toxicology, with personal accountability for scientific rigor and timelines
- Select and manage the external CRO network, including overseas partners, for in vitro pharmacology, in vivo models, antibody/protein generation and cell line development, and hold them to Slate’s scientific standards and timelines
- Lead discovery-stage scientific due diligence for in-licensing, collaboration and acquisition opportunities
- Build and lead a discovery team known for scientific rigor and execution
Job details
- Published
- November 12, 2026
- Experience
- Senior
- Job source
- jworkable
- Workplace
- Hybrid · Raleigh, US
- First seen
- November 12, 2026
See how well you match this job
Log in or sign up and Eva will compare your profile with this role, explain your strengths and show what to improve.
Sign up to see your matchAlready have an account? Log inMore at Slate Medicines
Similar jobs from this company
Across the market
Similar jobs from other companies
- Senior Director, Discovery Sciences & TechnologiesGilead Sciences, Inc.Foster City, USOn-site
- ACD DISCOVERY SCIENCEMoffittMagnolia HospitalOn-site
- Head of Operations, Discovery SciencesNovartisCambridge, USOn-site$132,300–$245,700 per year
- Intern - Discovery Pharmaceutical SciencesMerck Sharp & Dohme LLCBoston, USOn-site$39,908–$111,111 per year
- Discovery and Translational Science ConsultantClarivate Analytics (Espana) SAUSpain - BarcelonaOn-site
- Chemical Biologist, Discovery SciencesNovartisCambridge (United States)On-site
Related job searches
Third-party content disclaimer
Full job descriptions are sourced directly from third-party applicant tracking systems (ATS), job boards, recruitment platforms, and employer career pages.
LiftmyCV does not claim ownership of this content or guarantee its accuracy or current availability. All original content is the intellectual property of the respective employers or other rights holders.
LiftmyCV hiring intelligence, availability checks, and related-job recommendations are generated from LiftmyCV data and public sources.
If you prefer, you may apply directly via the original listing for transparency.